Founded Date: 2012-01-01
Last Funding Type: Post-IPO Equity
Headquarters: Boston, Massachusetts, United States
Investors Number: 11.0
Technology: Biotechnology, Health Care, Medical Device
Employee Number: 101-250
Industry: End-to-End Drug Development
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-12-13
Funding Status: IPO
Total Funding: 224000000.0